In rodents, the Robo1 gene regulates midline crossing of major nerve tracts, a fundamental property of the mammalian CNS. However, the neurodevelopmental function of the human ROBO1 gene remains unknown, apart from a suggested role in dyslexia. We therefore studied axonal crossing with a functional approach, based on magnetoencephalography, in 10 dyslexic individuals who all share the same rare, weakly expressing haplotype of the ROBO1 gene. Auditory-cortex responses were recorded separately to left-and right-ear sounds that were amplitude modulated at different frequencies. We found impaired interaural interaction that depended on the ROBO1 in a dosedependent manner. Our results indicate that normal crossing of the auditory pathways requires an adequate ROBO1 expression level.
Introduction
In the mammalian CNS, brain commissures and a significant part of the afferent and efferent pathways cross the midline. A key regulator of an analogous axonal crossing in the fruit fly, Drosophila, is the robo receptor (Seeger et al., 1993; Kidd et al., 1998a,b) that binds the chemorepulsive ligand slit at the midline (Brose et al., 1999; Kidd et al., 1999) . In the rodent nervous system, orthologous Robo1 and Robo2 genes (Kidd et al., 1998a ) and a structurally divergent Robo3 gene (Yuan et al., 1999) are expressed. In humans, mutations of ROBO3 impair crossing of somatosensory and motor pathways, as was demonstrated in patients with a syndrome of horizontal gaze palsy with progressive scoliosis (Jen et al., 2004; Sicotte et al., 2006; Avadhani et al., 2010; Ng et al., 2011) . However, the neurodevelopmental roles of the human ROBO2 and ROBO1 genes remain unclear, apart from the suggested involvement of ROBO1 in dyslexia (Hannula-Jouppi et al., 2005) and possibly in autism (Anitha et al., 2008) ; the linkage between dyslexia and the genomic region (3p13) near ROBO1 has also been demonstrated in a large genome-wide scan (Fisher et al., 2002) . All homozygous Robo1 knock-out mice died at birth and displayed large tight fascicles of non-crossing callosal axons, whereas the anatomic structures of heterozygous Robo1 ϩ/Ϫ mice seemed normal (Andrews et al., 2006) .
Because no homozygous human ROBO1 mutations are available, we recruited members of a Finnish family (see Fig. 1 ) in whom a rare but specific, weakly expressing haplotype of ROBO1 (Hannula-Jouppi et al., 2005) cosegregates with dyslexia in a dominant manner (Nopola-Hemmi et al., 2001) . Because dyslexia associates with various auditory disorders (Hari and Renvall, 2001 ) and because animal studies suggest minimal anatomical abnormalities in individuals with non-total ROBO1 defect, we applied a sensitive electrophysiological biomarker of functional crossing in auditory pathways.
Normally, the majority of axons from each ear cross the midline at several levels and reach the contralateral auditory cortex, whereas the rest project to the ipsilateral side (see Fig. 2A ). Thus, the auditory cortices of each hemisphere receive input from both ears. Cortical steady-state responses to sounds from one ear are weaker during binaural than monaural listening, indicating binaural suppressive interaction (Fujiki et al., 2002; Kaneko et al., 2003) . The suppression is stronger for ipsilateral than contralateral sounds and requires convergence of the inputs from both ears somewhere in the auditory pathways. We thus hypothesized that weaker crossing of axons as a result of deficient ROBO1 functioning would manifest as decreased binaural suppression of the ipsilateral responses. An auditory pathway from the ipsilateral ear to the cortex does not cross the midline itself, and thus the convergence, and the binaural suppression, has to rely on the crossing axons from the opposite side.
We studied binaural suppression-and thereby indirectly the strength of crossing in auditory pathways-in individuals with the ROBO1 gene defect by "frequency-tagging" magnetoencephalographic (MEG) steady-state responses, a method used previously in nonclinical studies (Fujiki et al., 2002; Kaneko et al., 2003) .
Materials and Methods
Subjects. The ROBO1 group comprised 10 dyslexic individuals (four females and six males; ages 19 -51 years; mean Ϯ SD, 31.0 Ϯ 12.3 years) from a Finnish family ( Fig. 1) (Nopola-Hemmi et al., 2002) , all sharing the same rare, weakly expressing haplotype of the ROBO1 gene that cosegregates with dyslexia in a dominant manner and has not been found in other families (Hannula-Jouppi et al., 2005) . The haplotype covers the whole genomic area of ROBO1; it is situated between the microsatellite markers D3S3039 and D3S3045 and includes two silent, single nucleotide polymorphisms (SNPs), one exonic insertion/deletion polymorphism and four SNPs in the 3Ј UTR in the ROBO1 gene (Nopola-Hemmi et al., 2001; Hannula-Jouppi et al., 2005) . According the neuropsychological test results (Nopola-Hemmi et al., 2002) , two subjects have severe dyslexia and five subjects have mild or compensated dyslexia. Three subjects were younger than 13 years of age at the time of neuropsychological testing; thus, the severity of their dyslexia was not categorized. Two of our 10 subjects had participated in the previous study (Hannula-Jouppi et al., 2005) who demonstrated attenuated expression level of the dyslexialinked allele (on average, 66% of the expression of the other allele). The control group in the MEG study comprised 10 healthy, non-dyslexic sexand age-matched individuals (ages 18 -49 years; mean Ϯ SD, 31.8 Ϯ 12.5 years).
All subjects of the MEG experiment were right-handed (Edinburgh Handedness Inventory scores of 78.9 -100 and mean of 94.7 for ROBO1 group; and scores of 76.5-100 and mean of 95.9 for controls). The audiograms were normal (within 20 dB hearing level) between 125 and 3000 Hz in every subject.
Because no blood samples from the MEG control group were available, preexisting samples of 10 anonymous healthy blood donors recruited by the Finnish Red Cross Blood Service were used as control data in the ROBO1 expression analysis.
The study protocol had previous permission from the local ethics committee, and all experiments were undertaken with the informed consent of the subjects.
The electrophysiological biomarker. Axonal crossing of auditory pathways was studied via binaural suppression using "frequency-tagged" stimuli, that is, left-and right-ear sounds amplitude modulated at different frequencies (Fig. 2 B) . The tagged auditory-cortex responses were selectively extracted from each hemisphere with magnetoencephalography with a method previously developed in our laboratory (Fujiki et al., 2002; Kaneko et al., 2003) . By means of the modulation frequencies, MEG signals for the left and right-ear inputs of the binaural stimuli can be separated from each other and then compared with the monaural responses to quantify the binaural suppression.
The stimulation and analysis were based on previous nonclinical studies of frequency-tagged auditory inputs (Fujiki et al., 2002; Kaneko et al., 2003) . We delivered, via plastic tubes and earpieces, continuous 1 kHz tones that were amplitude modulated with 100% depth at 41.1 Hz in the left ear and at 39.1 Hz in the right ear (Fig. 2 B) . The three different stimuli (left monaural, right monaural, binaural) were repeated once and presented in random order across subjects. Each stimulus lasted for 120 s, and the interstimulus interval was 5 s.
Sound intensity was set at the loudest but still comfortable listening level (60 -75 dB above the individual hearing threshold; mean Ϯ SEM, 70 Ϯ 1.5 for ROBO1 group and 71 Ϯ 1.4 for control subjects); intensity changes have no effect on the magnitude of binaural interaction within the range of 45-75 dB sensation level (Kaneko et al., 2003) and thus to the focus of this study. The subjects were instructed to keep their eyes open during the experiment.
Brain signals were measured in a magnetically shielded room with a whole-scalp neuromagnetometer (Vectorview; Elekta Oy) containing 102 sensor units, each comprising one magnetometer and two orthogonal planar gradiometers. The raw data were filtered from 0.03 to 200 Hz and sampled at 600 Hz. Traces contaminated by eye blinks and eye movements were rejected on the basis of a simultaneously measured vertical electro-oculogram.
MEG signals were averaged, time locked to the phase of the amplitude modulation; the analysis epochs comprised six modulation cycles, and altogether ϳ2000 epochs were averaged. Responses evoked by left-and right-ear inputs (both during monaural and binaural stimuli) were averaged, time locked to the 41.1 and 39.1 Hz modulation frequencies, respectively. The resulting steady-state responses (left monaural, right monaural, left binaural, right binaural) were bandpassed to 32-48 Hz by a non-causal FFT-based filter using a Hanning window. The filtering causes no phase shifts but dampens the outermost parts of the signal. We therefore used only the two middle cycles of the epochs of six cycles for signal strength quantification.
The steady-state responses to repeated stimuli were inspected for replicability and then averaged. Because of technical artifacts, no replication was available for one control subject and one ROBO1 subject.
Because planar gradiometers show the maximum signal directly above an active brain area, gradiometer pairs of four adjacent sensor units, including the gradiometer with the maximum steady-state response, were used for quantifying the neural activity in the left and right auditory cortices. For each gradiometer pair, the vector sum of the two orthogonally measured steady-state responses was calculated (that is, at each time point, the squared values of both gradiometer signals were summed, and then the square root of the sum was computed); the vector sums of four gradient pairs were averaged. The maximum strengths of these mean vector sums (areal average responses) were determined separately in the left (LH) and right (RH) hemispheres, and strengths of responsesevoked by the same input in the same ear-were compared during binaural and monaural stimulation. Suppression of responses during binaural stimulation was reported as a percentage decrease from corresponding monaural response.
Additional source analysis was performed for 10 control subjects and for eight ROBO1 subjects in the LH and for nine in the RH. The responses of one excluded subject were extremely weak in the LH, and the data of the other excluded subject were very noisy, thus preventing reliable source modeling. The magnetic field patterns evoked by monaural stimuli were modeled by two equivalent current dipoles, one in each hemisphere, to explain signal variability in 26 planar gradiometer channels over each temporal lobe (goodness-of fit Ͼ80%). These monaural dipoles were also used to model the corresponding steadystate responses elicited by the frequency-tagged binaural stimuli, and binaural suppression was measured based on peak-to-peak values of the source waveforms.
RNA extraction and cDNA synthesis. RNA samples from 10 ROBO1 subjects were extracted from Epstein-Barr virus (EBV)-transformed lymphocyte cell lines. Control RNA samples from 10 anonymous blood donors, used previously in another study, were extracted from isolated peripheral blood mononuclear cells.
RNA extraction from all samples was performed using RNeasy Plus Mini kit (Qiagen) that includes the removal of genomic DNA with a gDNA Eliminator spin column. The yield and purity of the RNA extracts were measured using a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific). cDNA syntheses were performed (900 ng of total RNA in a reaction volume of 50 l) using Taqman Reverse Transcription Reagents with random hexamer primers (Applied Biosystems).
ROBO1 expression assay. To study mRNA levels of ROBO1, the cDNA samples were subjected to quantitative real-time PCR (qRT-PCR) on an Applied Biosystems ABI Prism 7900 HT Sequence Detection System using predeveloped TaqMan gene expression assays. The samples were run in triplicates with a reaction volume of 10 l on a single 384-well plate. The threshold cycles (Ct) measured with the ROBO1 assay (Hs00268049_m1) were normalized to the geometric mean of two reference genes, GAPDH (assay 4310884E) and 18S rRNA (assay 4310893E), using the comparative Ct method (all instruments and reagents from Applied Biosystems). For the dose analysis with MEG data, the normalized Ct values (⌬Ct) were subtracted from the highest individual ⌬Ct value, resulting in ⌬⌬Ct values with logical order, with higher numbers indicating stronger expression. The expression levels of the two ROBO1 transcript variants were measured similarly, using the specific ROBO1a (NM_002941.3, assay Hs01560564_m1) or ROBO1b (NM_133631.3, assay Hs01560560_m1) assays.
Statistical analysis. The results of the control subjects were analyzed by a two-way within-subjects ANOVA. To compare the ROBO1 and control groups, we performed a 2 ϫ 2 ϫ 2 mixed ANOVA design in which subject group was a between-subject factor and ear of stimulation (ipsilateral vs contralateral) and hemisphere (LH vs RH) were within-subjects factors. For detailed examination of the interaction found in the mixed ANOVA, an additional ANOVA focusing on the ipsilateral suppressions and another ANOVA for contralateral suppression were used.
Results

Binaural suppression
In healthy control subjects-in line with previous results (Fujiki et al., 2002; Kaneko et al., 2003) -the sinusoidal steady-state auditory-cortex responses to amplitude modulated tones (Fig.  2C , top) were smaller to binaural (dashed lines) than monaural (solid lines) stimulation, especially for inputs from the ipsilateral ear. The binaural suppression was significantly stronger for the ipsilateral than the contralateral inputs (F (1,9) ϭ 27.67, p ϭ 0.001, partial 2 ϭ 0.76; mean Ϯ SEM suppression in the LH, 42.5 Ϯ 6.1 vs 14.8 Ϯ 3.7%; in the RH, 46.6 Ϯ 6.4 vs 14.9 Ϯ 4.8%). The hemisphere (LH or RH) had no main effect on the suppression, and no significant interactions were found.
In contrast to control subjects, ROBO1 subjects showed only minimal ipsilateral suppression of the steady-state responses (Fig. 2C, bottom) ; accordingly, the mixed ANOVA revealed significant interaction between the subject group (ROBO1 vs controls) and ear of stimulation (ipsilateral vs contralateral) (F (1,18) ϭ 11.79, p ϭ 0.003, partial 2 ϭ 0.40). A more detailed evaluation of this interaction demonstrated that the ipsilateral suppression (Fig. 2 D, left) was statistically significantly weaker in the ROBO1 group than in the control subjects (F (1,18) ϭ 7.78, p ϭ 0.012, partial 2 ϭ 0.30; mean Ϯ SEM suppression, 10.8 Ϯ 10.2 vs 42.5 Ϯ 6.1% in the LH and 13.9 Ϯ 12.2 vs 46.6 Ϯ 6.4% in the RH). Contralateral suppressions (Fig. 2 D, right) did not differ between the ROBO1 and control groups (F (1,18) ϭ 0.30, p ϭ 0.59, partial 2 ϭ 0.02; mean Ϯ SEM suppression, 11.6 Ϯ 6.7 vs 14.8 Ϯ 3.7% in the LH and 11.5 Ϯ 5.5 vs 14.9 Ϯ 4.8% in the RH). The additional source analysis (see Materials and Methods) provided practically identical results.
Correlation between ipsilateral suppression and gene expression
To examine the relationship between the abnormal ipsilateral suppression found in the ROBO1 subjects and the expression levels of their ROBO1, we performed expression analysis by qRT-PCR. RNA used in the qRT-PCR was extracted from lymphocytes, which are commonly used as models of neuronal gene expression (Gladkevich et al., 2004) .
In both hemispheres, the ipsilateral suppression weakened along with the ROBO1 gene expression level ( Fig. 3; Pearson's correlations in the LH, r ϭ 0.75, p Ͻ 0.02 and in the RH, r ϭ 0.78, p Ͻ 0.01; qRT-PCR results shown as ⌬⌬Ct values, with higher numbers indicating stronger ROBO1 expression). The expression analysis was performed twice with similar results, and the correlations were confirmed by the additional source analysis of subjects with reliable modeling (eight in the LH, nine in the RH).
Expression of ROBO1 transcript variants
Because ROBO1 encodes two different proteins of possibly distinct developmental roles, we studied the expressions of a longer transcript variant, ROBO1a, and a shorter form, ROBO1b (aka DUTT1) separately. ROBO1a and ROBO1b are derived from the alternative transcription initiation sites and spliced differentially, and they share the majority of the coding sequences (Clark et al., 2002) . In mice, Robo1b is the predominant isoform, showing wide expression in both neurodevelopment and adult tissues, whereas the expression of Robo1a is weaker, as well as more temporally and spatially restricted; in adult mice, Robo1a has been found only in brain, kidney, and eye (Clark et al., 2002; Nural et al., 2007) .
In our qRT-PCR analysis, the overall expression of ROBO1 (used in the dose analysis with MEG data) correlated very strongly with the ROBO1b expression (for each analysis, r Ͼ 0.99), in line with previous animal studies (Clark et al., 2002; Nural et al., 2007) . In contrast, ROBO1a was not expressed in blood at reliable or detectable levels (Ct values Ͼ35 or undetermined).
We further tested the validity of the isoform-specific assays used in expression analysis in commercially available brain cDNA samples. Both probes showed highest expression in developing fetal brain, and ROBO1b was expressed more strongly than ROBO1a in all brain areas (data not shown).
ROBO1 expression in healthy control subjects
We aimed to compare total ROBO1 expression levels between the ROBO1 subjects and healthy individuals, although the partial haploinsufficiency of the ROBO1 gene [that is, one functional copy and one weakly expressing copy of the gene (HannulaJouppi et al., 2005) ] most probably decreases the total biallelic ROBO1 expression only slightly in our ROBO1 subjects. For this additional analysis, preexisting blood samples from 10 anonymous blood donors were exploited. Both the ROBO1 group and the blood donors showed wide variability in the individual expression levels, and no statistically significant difference in the total biallelic expressions between the ROBO1 subjects and blood donors was found (mean Ϯ SD expression in terms of ⌬Ct, normalized against the geometric mean of GADPH and 18S rRNA, 15.9 Ϯ 2.1 vs 14.9 Ϯ 1.7, respectively). Left hemisphere Right hemisphere ROBO1 expression ( Ct) Figure 3 . Dependence of the ipsilateral suppression on lymphocyte ROBO1 mRNA level in ROBO1 subjects. ROBO1 expression levels are shown as ⌬⌬Ct values; the higher number indicates stronger expression (Ct in qRT-PCR were normalized first against the geometric mean of GAPDH and 18S rRNA and then against the highest individual value). The regression lines and the correlation coefficients show that decreasing gene expression is associated with weaker ipsilateral suppression in both hemispheres. The additional source analysis of eight subjects in the LH and nine subjects in the RH confirmed the relationship; the subjects with unreliable source modeling are colored gray.
Like the ROBO1 group, the blood donors showed undetectable or minimal (Ct values Ͼ35) ROBO1a expressions, and the ROBO1b expression correlated with the overall ROBO1 expression (r ϭ 0.94).
Discussion
Novel biomarker and a rare family in revealing the functions of ROBO1 Our combination of an electrophysiological biomarker of auditory pathway crossing with gene expression analysis demonstrated clearly defective interaural interaction in subjects with a weakly expressing haplotype of the ROBO1 gene. Importantly, the extent of the deficit correlated with ROBO1 expression level. The family we examined, which is the only known subgroup of individuals with a rare, specific, weakly expressing haplotype of ROBO1, provided an exceptional opportunity to explore both the role of ROBO1 in the human CNS and the effects of genetic variance on the functions guided by ROBO1. The results demonstrate the significance of the human ROBO1 gene in auditory processing and brain development and link, for the first time, a potential dyslexia susceptibility gene to a specific sensory function of the human brain.
Binaural suppression as a measure of axonal crossing
The weakened suppression of ipsilateral inputs in the ROBO1 group supports our hypothesis of defective axonal midline crossing caused by partial ROBO1 haploinsufficieny. According to the well-established anatomy of the auditory pathways, the weakened suppression most likely reflects deficient midline crossing in the auditory pathways.
The electrophysiological findings in our ROBO1 subjects were stronger than what would be expected on the basis of animal studies. Homozygous Robo1 knock-out mice can display large defects in corpus callosum and in other nerve tracts crossing the midline (Andrews et al., 2006) ; however, in an another knock-out study, only minor defects were detected in corpus callosum (Ló pez-Bendito et al., 2007) . No reports exist about anatomical abnormalities in heterozygous Robo1 knock-out mice, evoking the possibility that one normally expressing copy of the Robo1 gene is enough for normal embryonic development (Hernández-Miranda et al., 2011) . The clear functional defect found in our subjects who have one normal and one weakly expressing allele of ROBO1 (Nopola-Hemmi et al., 2001 ) could reflect, beyond the sensitivity of the applied electrophysiological method, abnormalities already in the inferior colliculus (IC), a structure important for binaural hearing (Moore, 1991) . In rat embryos, Robo1 mRNA has been observed in both IC and the more peripheral cochlear nucleus (Marillat et al., 2002) . Of course, small abnormalities along the auditory pathways, for example deficient midline crossing of the auditory axons at several levels, may accumulate along the whole pathway.
In addition to a major role in axonal midline guidance, Robo1 also controls the migration of GABAergic interneurons from telencephalon to rodent cortex (Andrews et al., 2006 (Andrews et al., , 2008 Hernández-Miranda et al., 2011) . GABA, as the most important inhibitory neurotransmitter in the mammalian brain, modulates binaurally responding cells in the bat auditory cortex (Razak and Fuzessery, 2010) . However, without abnormal crossing, altered GABA-mediated inhibition would be unlikely to produce such strong defects as were found for the ipsilateral inputs.
In our ROBO1 subjects, the abnormal ipsilateral suppression correlated with the ROBO1 expression levels in a dose-dependent manner and in both hemispheres: the weaker the expression, the more abnormal was the interaural interaction.
The roles of splicing variants ROBO1a and ROBO1b
Our current results, coinciding with the animal studies (Clark et al., 2002; Nural et al., 2007) , demonstrate that the expression of the splicing variant ROBO1b accounts for the great majority of the overall expression of ROBO1 in adult human lymphocytes. Because the overall expression of ROBO1 is attenuated from the dyslexia-associated allele (Hannula-Jouppi et al., 2005) , we conclude that, in ROBO1 subjects, the expression of the shorter transcript, ROBO1b, is defective. Because the coding sequences of the ROBO1b and ROBO1a extensively overlap (Clark et al., 2002) , the defective expression of both splicing variants is highly probable. In a dyslexic subject with a translocation disrupting only the ROBO1a transcript-not ROBO1b-the expression of ROBO1b was suggested to be biallelic (Hannula-Jouppi et al., 2005) . However, the translocation breakpoint in the intron of ROBO1a may also modulate the expression of adjacent ROBO1b. ROBO1a is expressed especially in the auditory areas, whereas ROBO1b is expressed more evenly throughout the mid-fetal neocortex (Johnson et al., 2009 ). We were not able to evaluate the expression levels of ROBO1a, and additional studies are needed for clarification of the different roles of the two splicing variants.
ROBO1 expression in healthy versus ROBO1 subjects According to the previously established partial haploinsufficiency of ROBO1 subjects (Hannula-Jouppi et al., 2005) , only small differences in the total biallelic expression levels between the healthy individuals and ROBO1 group were expected. In a previous study (Hannula-Jouppi et al., 2005) , the expression of the dyslexia-linked allele was on average 66% of the expression of the same allele in control subjects, corresponding to 83% (ϭ166%/2) of normal biallelic expression level and a difference of only 0.27 in ⌬Ct values between the ROBO1 group and control subjects (83% ϭ 2 Ϫ0.27 ). Notably, ROBO1 expression levels were measured in white blood cells, because no brain cells were available for obvious reasons. Although the dyslexia-linked allele would be totally inactive in all ROBO1 subjects, meaning that the healthy individuals express ROBO1 on average approximately two times more than ROBO1 subjects, the mean ⌬Ct value would be approximately one cycle higher in the ROBO1 group than in healthy individuals, as it actually was in our study (15.9 in ROBO1 group vs 14.9 in healthy controls). However, the difference did not reach statistical significance in our group of 10 subjects. The slightly different RNA extraction methods (i.e., EBV-transformed lymphocytes in the ROBO1 group vs peripheral blood mononuclear cells in the control group) most likely had no significant effect on the results because most genes are expressed similarly in those two cell lines (Rollins et al., 2010) . Furthermore, the results are well in line with the underlying partial haploinsufficiency.
An extremely interesting question is why healthy individuals behave normally despite large individual variability of total biallelic expression levels, whereas subjects with moderately weakened expression from the other ROBO1 allele show clearly defective auditory processing and abnormal phenotype. Because of temporal and spatial changes in ROBO1 expression, the differences in biallelic expression levels between healthy individuals and ROBO1 subjects may be much more substantial in developing fetal brain than in adult lymphocytes. In addition, some deficits primarily caused by small developmental disorders may be accentuated during later development as a result of behavioral abnormalities.
ROBO1 in dyslexia and related disorders
Among the four currently most noteworthy candidates for dyslexia genes, ROBO1 seems to differ functionally from the three other genes: in rodents, DYX1C1, DCDC2, and KIAA0319 orthologs have no role in axonal midline guidance and tangential migration of interneurons but instead participate in radial migration. In healthy subjects, ROBO1 associates with language deficits, specifically with phonological buffer deficit (Bates et al., 2011) . It has also been linked to autism (Anitha et al., 2008) . Dyslexia and a specific language impairment (SLI) are comorbid disorders, and early SLI predicts later dyslexia (Snowling et al., 2000) . Interestingly, an SLI-related phenotype, speech sound disorder, has shown linkage to the region on chromosome 3 in which ROBO1 is located (Stein et al., 2004) . Thus, revealing the roles of ROBO1 in human neurodevelopment seems highly relevant.
